Roslyn Tedja
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Ovarian cancer diagnosis and treatment
Papers in
-
- Epigenetics and DNA Methylation 2
- Glycosylation and Glycoproteins Research 1
- Ubiquitin and proteasome pathways 1
- Oncology 6
- Cancer-related Molecular Pathways 2
- Cancer Cells and Metastasis 2
- Co-authors
- Christopher P. Marquis (3 shared papers)May Lim (3 shared papers)Rose Amal (3 shared papers)Cai M. Roberts (4 shared papers)Carlos Cárdenas (4 shared papers)Ayesha B. Alvero (11 shared papers)Gil Mor (11 shared papers)Yang Yang‐Hartwich (2 shared papers)
- Journals
- Cancers (4 papers)Frontiers in Oncology (1 paper)Journal of Biological Chemistry (1 paper)ACS Nano (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Roslyn Tedja
15 papers receiving 430 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 65
- Reproductive Medicine 29
- Cancer Research 50
- Oncology 77
- Surfaces, Coatings and Films 21
Countries citing papers authored by Roslyn Tedja
This map shows the geographic impact of Roslyn Tedja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roslyn Tedja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roslyn Tedja more than expected).
Fields of papers citing papers by Roslyn Tedja
This network shows the impact of papers produced by Roslyn Tedja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roslyn Tedja. The network helps show where Roslyn Tedja may publish in the future.
Co-authors
The 25 scholars most cited alongside Roslyn Tedja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 130 | |
| 2 | 2019 | 51 | |
| 3 | 2018 | 43 | |
| 4 | 2011 | 43 | |
| 5 | 2012 | 42 | |
| 6 | 2020 | 30 | |
| 7 | 2019 | 29 | |
| 8 | 2022 | 16 | |
| 9 | 2023 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2023 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 5 | |
| 14 | 2024 | 2 | |
| 15 | 2023 | 2 |
About Roslyn Tedja
Roslyn Tedja is a scholar working on Molecular Biology, Oncology, Reproductive Medicine, Immunology and Cancer Research, having authored 15 papers that have together received 434 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Cancer-related Molecular Pathways (2 papers), Nanoparticles: synthesis and applications (2 papers), Cancer Cells and Metastasis (2 papers), Epigenetics and DNA Methylation (2 papers), Glycosylation and Glycoproteins Research (1 paper), Ubiquitin and proteasome pathways (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Biomaterials (65 citations), Reproductive Medicine (29 citations), Cancer Research (50 citations), Oncology (77 citations) and Surfaces, Coatings and Films (21 citations). Roslyn Tedja has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Christopher P. Marquis, May Lim, Rose Amal, Cai M. Roberts, Carlos Cárdenas, Ayesha B. Alvero, Gil Mor, Yang Yang‐Hartwich, Mary Pitruzzello and Carlotta A. Glackin. Their work appears in journals such as Cancers, Frontiers in Oncology, Journal of Biological Chemistry, ACS Nano and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.